Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Relationships between the endothelin and nitric oxide pathways.

T D Warner1

  • 1William Harvey Research Institute, St Bartholomew's, London, UK. t.d.warner@mds.qmw.ac.uk

Clinical and Experimental Pharmacology & Physiology
|March 19, 1999
PubMed
Summary

Nitric oxide (NO) and endothelin-1 (ET-1) are key mediators in blood vessel regulation. Their balance is crucial, with NO acting as a vasodilator and ET-1 as a vasoconstrictor, impacting blood pressure and vascular health.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Platelet responses to pharmacological and physiological interventions in middle-aged men with different habitual physical activity levels.

Acta physiologica (Oxford, England)·2018
Same author

Inhibition of platelet aggregation ex vivo is repressed in apolipoprotein E deficient mice.

Canadian journal of physiology and pharmacology·2017
Same author

Why Neighborhoods (and How We Study Them) Matter for Adolescent Development.

Advances in child development and behavior·2017
Same author

Pharmacological assessment of ibuprofen arginate on platelet aggregation and colon cancer cell killing.

Biochemical and biophysical research communications·2017
Same author

Perceptions of African-American health professionals and community members on the participation of children and pregnant women in genetic research.

Public health genomics·2013
Same author

Antiplatelet effects of aspirin vary with level of P2Y₁₂ receptor blockade supplied by either ticagrelor or prasugrel.

Journal of thrombosis and haemostasis : JTH·2011

Area of Science:

  • Vascular Biology
  • Endocrinology
  • Physiology

Background:

  • The vascular endothelium regulates smooth muscle tone and blood element reactivity via mediators like nitric oxide (NO) and endothelin-1 (ET-1).
  • NO is a vasodilator inhibiting platelet and neutrophil aggregation, while ET-1 is a potent vasoconstrictor.
  • Interactions between NO and ET-1 are critical: ET-1 stimulates NO release, and NO inhibits ET-1 production.

Purpose of the Study:

  • To examine the interactions between nitric oxide (NO) and endothelin-1 (ET-1) in regulating vascular function.
  • To understand the roles of NO and ET-1 in both normal physiological conditions and pathological vascular states.

Main Methods:

  • This study reviews existing research on the interplay between NO and ET-1.
  • Analysis of mediator interactions in endothelial cells and vascular smooth muscle.

Related Experiment Videos

  • Examination of the physiological and pathophysiological implications of NO and ET-1 balance.

    • Main Results:

    • NO plays a central role in basal blood pressure regulation; its inhibition markedly elevates blood pressure.
    • Vascular diseases are linked to increased ET-1 production, implicated in ischemia-reperfusion injury, subarachnoid hemorrhage, and hypertension.
    • In pathological conditions, NO production can increase in vascular smooth muscle, and ET-1 may also be produced by smooth muscle cells.

    Conclusions:

    • The balance between NO and ET-1 production is central to pathological changes in blood vessel reactivity, smooth muscle proliferation, and blood coagulability.
    • Understanding the NO-ET-1 axis is vital for addressing various vascular diseases.